Carprieve Injection
Carprieve injection is a sterile injection containing 50mg/mL carprofen in an amber multidose glass vial. In the dog it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intra-ocular) surgery; in the cat for the control of postoperative pain following surgery; and in the horse for the treatment of musculo-skeletal disorders and for anti-inflammatory treatment after surgery.
Target Species: Dogs, cats, horses
-
Active Ingredient
50mg/mL carprofen
-
Pharmaceutical Form
Solution for injection
-
Indications
It is indicated in the dog for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intra-ocular) surgery; in the cat for the control of postoperative pain following surgery; and in the horse for the treatment of musculo-skeletal disorders and for anti-inflammatory treatment after surgery.
-
Dosage
Dogs: The recommended dosage is 4 mg/kg (1ml/12.5 kg) bodyweight. To be administered by intravenous or subcutaneous injection. This dose can be repeated again after 24 hours and can be followed by Carprieve Tablets for up to 5 days. Cats: The recommended dosage is 4 mg/kg (0.24ml/3 kg) bodyweight. To be administered by intravenous or subcutaneous injection. To measure the dose accurately, a 1mL graduated syringe is recommended. Horses: For intravenous use only. The recommended dosage is 0.7 mg/kg (1ml/70kg) bodyweight as a single dose. This dose can be repeated after 24 hours or can be followed by oral NSAID therapy for up to 5 days. After this period, another clinical evaluation is required.
Prefer to speak directly to a member of our team?
Norbrook® Laboratories New Zealand Ltd
We are open Mon - Fri 9:00am - 5:00pm
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.